Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL)

Cytometry Part B - Clinical Cytometry

Volumn 70, Issue 4, 2006, Pages 293-301

  Bojarska Junak, Agnieszka ^a   Giannopoulos, Krzysztof ^a   Kowal, Malgorzata ^a   Dmoszyńska, Anna ^a   Roliński, Jacek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

B cell chronic lymphocytic leukemia (B CLL); Flow cytometry; Zeta chain associated protein 70 (ZAP 70)

Indexed keywords

ALCOHOL; FLUOROCHROME; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; PARAFORMALDEHYDE; PROTEIN KINASE ZAP 70; REAGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER PATIENT; CELL ISOLATION; CELL PERMEABILIZATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; INTERMETHOD COMPARISON; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; CELL MEMBRANE PERMEABILITY; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33748484706     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20133     Document Type: Article

References (27)

1. Dighiero G. CLL Biology and Prognosis. Hematology (Am Soc Hematol Educ Program). 2005:278-284.
2. Bosch F, Villamor N. ZAP-70 expression in chronic lymphocytic leukaemia derived from a multivariate survival analysis. Cancer 2003;48:198-206.
3. Polliack A. Current therapeutic options for subgroups of chronic lymphocytic leukaemia. Planning risk-adapted treatment according to recognized prognosis factors. Haematologica 2003;88:726-728.
4. Döehner H, Stilgenbauer S, Benner, et al. Genomic aberration and survival in chronic lymphocytic leukaemia. N Engl J Med. 2000;343:1910-1916.
5. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
6. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD 38 expression as a novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
7. Kröber A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-1416.
8. Crespo M, Bosch F, Villamor N, et al. ZAP-70 Expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-75.
9. Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002;99:1023-1029.
10. Schroers R, Griesinger F, Trümper L, et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukaemia. Leukemia 2005;19:750-758.
11. Rassenti L, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukaemia. N Engl J Med 2004;351:893-901.
12. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992;71:649-662.
13. Chen L, Widhopf G, Huynh L, et al. Expression of ZAP-70 is associated with increased B-cell receptor signalling in chronic lymphocytic leukaemia. Blood 2002;100:4609-4614.
14. Bojarska-Junak A, Roliński J, Kawiak J. Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia. Folia Histochem Cytobiol. 2005;45:19-23.
15. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
16. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
17. Zwiebel JA, Cheson BD. Chronic lymphocytic leukemia: staging and prognosis factors. Semin Oncol 1998;25:42-59.
18. Montserrat E. Classical and new prognostic factors in chronic lymphocytic leukemia: where to now? Haematol J 2002;3:7-9.
19. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneus phenotype related to memory B cells. J Exp Med 2001;194:1625-1638.
20. Hamblin AD, Hamblin TJ. Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia. Expert Opin Ther Targets 2005;9:1165-1178.
21. Gibbs G, Bromidge T, Howe D, et al. Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. Clin Lab Haematol. 2005;27:258-266.
22. Francis C, Connelly MC. Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood. Cytometry 1996;25:58-70.
23. Millard I, Degrave E, Philippe M, Gala JL. Detection of intracellular antigens by flow cytometry: comparison of two chemical methods and microwave heating. Clinical Chemistry 1998;44:2320-2330.
24. Nicholson JK, Jones BM, Cross GD, McDougal JS. Comparison of T and B cell analyses on fresh and aged blood. J Immunol Methods. 1984;73:29-40.
25. Romeu MA, Mestre M, Gonzalez L, et al. Lymphocyte immunophenotyping by flow cytometry in normal adults. Comparison of fresh whole blood lysis technique, Ficoll-Paque separation and cryopreservation. J Immunol Methods. 1992;154:7-10.
26. Kutvirt SG, Lewis SL, Simon TL. Lymphocyte phenotypes in infants are altered by separation of blood on density gradients. Br J Biomed Sci. 1993;50:321-328.
27. Pozarowski P, Halicka DH, Darzynkiewicz Z. NF-κB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures. Cytometry Part A 2003;54A:118-124.